Letters The truth about Tamiflu?
Data access is matter of trustBMJ 2010; 340 doi: https://doi.org/10.1136/bmj.c134 (Published 13 January 2010) Cite this as: BMJ 2010;340:c134
View Full Text
- Alan R Maryon-Davis, president1
- 1UK Faculty of Public Health, London NW1 4LB
The UK Faculty of Public Health strongly supports the BMJ’s call for mandatory disclosure of raw data of all trials cited in drug licensing applications and …